Gastrointestinal Flashcards
Coeliac disease
Inflammation of the mucosa of the upper small bowel in response to GLUTEN
AUTOIMMUNE (T cell mediated)
Intolerance to PROLAMIN (in wheat, barley, rye, oats) which is a component of gluten protein
Causes VILLOUS ATROPHY
Leads to MALABSORPTION
Coeliac disease epidemiology
1% of population in the UK
Peaks in infancy + 40-60 years
Familial link and risk in coeliac disease
10% risk in 1st degree relatives
HLA associated: HLA DQ2 (90%)
Coeliac disease risk factors
Other autoimmune diseases: T1DM, autoimmune thyroid, Addisons
Test all new cases of T1DM for coeliac
Pathophysiology coeliac disease
SMALL BOWEL (particularly the jejunum)
Gliadin = breakdown product of gluten
Tissue transglutaminase (tTG) Ab
Ab-gliadin complex is presented to a transferrin receptor
Endocytosed accross the gastric mucosa into lamina propria
Deamidation
Deamidated gliadin phagocytosed by HALDQ8 cells
Macrophages signal an immune response (pro-inflammatory cytokines > cascade)
Results in:
VILLOUS ATROPHY > malabsorption
CRYPT HYPERPLASIA
Raised intraepithelial lymphocytes
Clinical presentation of coeliac disease
Often asymptomatic Failure to thrive in young children Malabsorption (due to villous atrophy) - STEAORRHOEA (can’t absorb fat) - ANAEMIA (can’t absorb B12, folate, iron) - Osteomalacia (can’t absorb vitamin D) UNINTENTIONAL WEIGHT LOSS Fatigue DIARRHOEA Aphthous ulcers Angular stomatitis Dermatitis herpetiformis
Complications of untreated coeliac disease
Vitamin deficiency
Anaemia
Osteoporosis
Increased risk of malignancy:
Enteropathy-associated T-cell lymphoma
Investigations for coeliac disease
1st line: raised anti-tTG antibodies
- very high sensitivity and specificity
- false negatives may occur in people with IgA deficiency as anti-tTG is IgA
Gold standard: endoscopy + duodenal biopsy
- villous atrophy
- crypt hypertrophy
- raised intracellular WBCs
Can also test for IgA endomysial antibody (anti-EMA) but less sensitive
Treatment of coeliac
Lifelong gluten-free diet
Inflammatory Bowel Disease (IBD)
Chronic
Autoimmune
Umbrella term for two main diseases that cause inflammation of the GI tract:
Crohn’s disease
Ulcerative colitis
Relapsing & remitting
Key features of Crohns: NESTS
Not usually blood or mucus (but can occur)
Entire GI tract (mouth to anus)
Skip lesions on endoscopy (non-continuous inflammation)
Terminal ileum and Transmural
Smoking is a risk factor
Cobblestone appearance (ulcers and fissures in mucosa) Non-caseating granuloma inflammatory lesions
Key features of Ulcerative colitis: UC CLOSE UP
Continuous and circumferential inflammation; crypt abscesses Limited to colon and rectum ONLY superficial mucosa affected Smoking is protective Excrete blood and mucus
Use aminosalicylates and Uveitis
Primary sclerosis cholangitis and pseudo-polyps
DEPLETED goblet cells (mucosal barrier destruction)
Risk factors for ulcerative colitis
Family history
NSAIDs (can trigger onset and flares) Chronic stress (can trigger flares)
Ulcerative colitis epidemiology
Presentation at 20-40 years old
Higher incidence than Crohns
Incidence is 3x higher in non-smokers
Symptoms of UC
Diarrhoea
Abdominal pain
Passing blood and mucus
Weight loss
Signs of UC
Acute: fever, tachycardia, tender abdomen
Extraintestinal: clubbing, nutritional deficits
Complications of UC
Colon:
- Blood loss
- Colorectal cancer
Skin:
- Erythema nodosum
- Pyoderma gangrenosum
Joints:
- Ankylosing spondylitis
- Arthritis
Eyes:
- Uveitis
Liver:
- sclerosing cholangitis
Investigations of UC
Blood tests:
- raised CRP & ESR in active inflammation
- raised WCC
- raised platelets
- anaemia (normocytic of chronic disease)
- pANCA may be +ve (-ve in Crohn’s)
Gold standard:
- DIAGNOSIS: sigmoidoscopy + biopsy
- further: full colonoscopy + biopsy
Further testing:
Abdominal X-Ray
Ultrasound, CT and MRI
Treatment of UC
MILD TO MODERATE DISEASE 1st line: aminosalicylate - 5-aminosalicyclic acid (5-ASA) - sulfasALAZINE, mesALAZINE, olsALAZINE - oral or rectal route 2nd line: oral corticosteroids e.g. prednisolone
SEVERE DISEASE
1st line: IV corticosteroids e.g. hydrocortisone
2nd line: IV ciclosporin
SEVERE W/ NO RESPONSE: colectomy
- surgery is possible as it only affects the colon and rectum
MAINTAINING REMISSION: Aminosalicylate, AZATHIOPRINE
Crohn’s disease risk factors
Stronger genetic association than UC Family history Smoking NSAIDs (exacerbate) Chronic stress (trigger flares)
Crohn’s epidemiology
Northern Europe and North America
Females > males
Presentation mostly at 20-40 years
Crohn’s disease symptoms
Small bowel: Abdo pain, weight loss
Colon: Bloody diarrhoea, pain on defecation
Systemic: Fever, fatigue, anorexia
Crohn’s disease signs
Bowel ulceration
Abdo tenderness
Abdo mass
Extraintestinal:
oral aphthous ulcers (more common in Crohn’s than UC)
skin, joint and eye problems
Crohn’s disease complications
Malabsorption Small bowel obstruction Colorectal cancer Anaemia Perianal disease e.g. fissures